Buscar
Mostrando ítems 71-80 de 1019
Neuropsychological profile in the preclinical stages of dementia: Principal component analysis approach
(Universidad Nacional de San Agustín de ArequipaPE, 2021)
The preclinical stages of dementia include subtle neurocognitive changes that are not easily detected in standard clinical evaluations. Neuropsychological evaluation is important for the classification and prediction of ...
Vitamin D increases A beta 140 Plasma levels and protects Lymphocytes from oxidative death in mild cognitive impairment patients
(2018)
Background: Mild cognitive impairment (MCI) has an increased rate of progression to dementia. Alterations of some metabolic factors, such as deficiency of vitamin D, are a risk factor for cognitive deterioration. Vitamin ...
The Impact of a Yoga-Based Mindfulness Intervention versus Psycho-Educational Session for Older Adults with Mild Cognitive Impairment: The Protocol of a Randomized Controlled Trial
(2022)
Background: There is a global agreement in the medical community that a significant proportion of dementia cases could be prevented or postponed. One of the factors behind this agreement comes from scientific evidence ...
Executive dysfunction correlates with impaired functional status in older adults with varying degrees of cognitive impairment
(CAMBRIDGE UNIV PRESS, 2008)
Background: Previous studies have reported an association between executive dysfunction and the ability to perform activities of daily living (ADL)s among older adults. This study aims to examine the association between ...
Systematic review: microRNAs as potential biomarkers in mild cognitive impairment diagnosis
(Frontiers Media, 2022)
The rate of progression from Mild Cognitive Impairment (MCI) to Alzheimer's disease (AD) is estimated at > 10% per year, reaching up to 80-90% after 6 years. MCI is considered an indicator of early-stage AD. In this context, ...
The effect of a cognitive training therapy based on stimulation of brain oscillations in patients with mild cognitive impairment in a Chilean sample: study protocol for a phase IIb, 2 × 3 mixed factorial, double-blind randomised controlled trial
(2024)
Background: The ageing population has increased the prevalence of disabling and high-cost diseases, such as dementia and mild cognitive impairment (MCI). The latter can be considered a prodromal phase of some dementias and ...
Adding Recognition Discriminability Index to the Delayed Recall Is Useful to Predict Conversion from Mild Cognitive Impairment to Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative
(Frontiers Research Foundation, 2017-03)
Background: Ongoing research is focusing on the identification of those individuals with mild cognitive impairment (MCI) who are most likely to convert to Alzheimer's disease (AD). We investigated whether recognition memory ...
Frequency of APOE, ACE, MTHFR an CCR5 Polymorphisms in Patients with Mild Cognitive Impairment in Costa Rican Population
(2016-11-22)
Background: This is a descriptive cross-sectional epidemiological study describing the prevalence of
polymorphisms within the Apolipoprotein E (ApoE), Methylenetetrahydrofolate reductase (MTHFR), Angiotensin converting ...